Company: OCEA
Filing Date: 2025-01-15
Form Type: 8-K
Source: 0001493152-25-002237
Chunk: 0

Company: Ocean Biomedical, Inc.
Filing Date: 2025-01-15
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

Notice
from Nasdaq regarding Nasdaq Listing Requirement for Annual Meeting

On
January 7, 2025, the Company received a notice from Nasdaq that since the Company had not yet held an annual meeting of shareholders
within twelve months of the Company’s fiscal year ended December 31, 2023, it no longer complies with the Listing Rules (the “ Rules”)
for continued listing.( Listing Rules 5620(a) and 5810(c)(2)(G)). Accordingly, this matter serves as an additional basis for delisting
the Company’s securities from The Nasdaq Stock Market. This is formal notification that the Nasdaq Hearings Panel (the “ Panel”)
will consider this matter in their decision regarding the Company’s continued listing on The Nasdaq Capital Market. In that regard,
the Company should present its views with respect to this additional deficiency to the Panel in writing no later than January 14, 2025.
The Company plans on holding its annual meeting no later than March 31, 2025.

SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Date:
January 14, 2025

  OCEAN                                    
  By:                   /s/                
                        Jolie              
                        Chief